Beta-Adrenergic Blockade with Pindolol (LB-46) in Mild to Moderate Asthma Observations
Acceptable beta-adrenergic antagonists for use in patients with asthma should ideally minimize antagonism of bronchial (beta2) receptors while providing useful cardiac (beta2) blockade. Propranolol, a nonselective beta-adrenergic blocking drug, aggravates bronchospasm in asthmatics . Metoprolol, a selective betai blocker approved for use in the United States, may have decreased effect on the airways. However, its selectivity is thought to be dose-related and perhaps limited to the lower dose ranges. Pindolol (LB-46), a potent beta-adrenergic blocker, does not have